Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone
Product Images NDC 13985-016

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone (NDC 13985-016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mwi/vetone, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Neomycin Sulfate (structural Formula) (10195234 E8c4 455a 9e27 0333f454ea3f 01)

FDA Label Image

Polymyxin B Sulfate (structural Formula) (10195234 E8c4 455a 9e27 0333f454ea3f 02)

FDA Label Image

Bacitracin Zinc (structural Formula) (10195234 E8c4 455a 9e27 0333f454ea3f 03)

FDA Label Image

Hydrocortisone (structural Formula) (10195234 E8c4 455a 9e27 0333f454ea3f 04)

FDA Label Image

Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone Ophthalmic Ointment Usp (carton, 3.5 Gram (MWI))

Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone Ophthalmic Ointment Usp (carton, 3.5 Gram (MWI))
This text appears to be a product description for an ophthalmic (eye) ointment containing active ingredients such as Neomycin, Polymyxin B Sulfates, Bacitracin Zinc, and Hydrocortisone. The dosage instructions suggest applying the ointment every 3-4 hours, depending on the severity of the condition. The product is manufactured by Bausch & Lomb Incorporated and caution is advised not to contaminate the ointment. The text also includes information about net weight and storage requirements.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.